Higher raw material imports signal end of pharma sector’s slump – The Daily Star

The pharmaceutical sector’s slump may be coming to an end as higher raw material imports are being reported. This is a positive sign for the industry, indicating potential growth and recovery in the near future. The import of raw materials is a key indicator of production activity within the pharmaceutical sector, and an increase in imports suggests that manufacturers are gearing up for increased production. This could lead to higher output, increased sales, and ultimately, a boost for the industry as a whole. Overall, the rise in raw material imports is a promising development for the pharmaceutical sector and may signal the end of its recent slump.